Immune checkpoint inhibitors in cancer therapy: Review of orofacial adverse events and role of the oral healthcare provider

• Autores principales: Brittany A. Klein (Autor), Muhammad Ali Shazib (Autor), Alessandro Villa (Autor), Fábio de Abreu Alves (Autor), Piamkamon Vacharotayangul (Autor), Stephen Sonis (Autor), Stefano Fedele (Autor), Nathaniel S. Treister (Autor)
• Formato: Libro
• Publicado: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Immune checkpoint inhibitors (ICIs) are a revolutionary class of antineoplastic therapy that restore anti-tumor immunity. Consequences of this enhanced immune response include a multitude of immune related adverse events (irAEs) that can affect any body system, including the mouth. Orofacial irAEs r...